Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Oncology/Hematology Market Research

Global Liver Cancer Drugs Databank Market Report

Best Price Guarantee Length Publisher Published Date SKU
from $2,000 100 Pages Magna Intelligence April, 2024 MAIN18750194
Best Price Guarantee
Price from $2,000
Length 100 Pages
Publisher Magna Intelligence
Published Date April, 2024
SKU MAIN18750194

Global Liver Cancer Drugs Databank Market Report


The Liver Cancer Drugs market was valued at $2,415.6 Million in 2022, and is projected to reach $7,115.4 Million by 2031 growing at a CAGR of 12.82% from 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. Immunotherapy segment is anticipated to reach $1,575.0 Million by 2031 with the highest CAGR of 13.97%. Targeted Therapy and Immunotherapy segments collectively expected to account for about 79.9% share of the Liver Cancer Drugs market in 2022, with the former constituting around 59.7% share. Immunotherapy and Chemotherapy segments are expected to witness significant growth rates at a CAGR of 13.97% and 13.53% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 40.3% in the overall Liver Cancer Drugs market in 2022, and is anticipated to reach 43.4% by 2031.


1. Global Liver Cancer Drugs Market, By Drug Class
1.1. Overview
1.2. Targeted Therapy
1.2.1 Targeted Therapy Market, By Region
1.2.1.1 North America Targeted Therapy Market, By Country
1.2.1.2 Europe Targeted Therapy Market, By Country
1.2.1.3 Asia-Pacific Targeted Therapy Market, By Country
1.2.1.4 Rest of World Targeted Therapy Market, By Country
1.3. Immunotherapy
1.3.1 Immunotherapy Market, By Region
1.3.1.1 North America Immunotherapy Market, By Country
1.3.1.2 Europe Immunotherapy Market, By Country
1.3.1.3 Asia-Pacific Immunotherapy Market, By Country
1.3.1.4 Rest of World Immunotherapy Market, By Country
1.4. Chemotherapy
1.4.1 Chemotherapy Market, By Region
1.4.1.1 North America Chemotherapy Market, By Country
1.4.1.2 Europe Chemotherapy Market, By Country
1.4.1.3 Asia-Pacific Chemotherapy Market, By Country
1.4.1.4 Rest of World Chemotherapy Market, By Country
2. Global Liver Cancer Drugs Market, By Region
2.1. Overview
2.2. North America
2.2.1 North America Liver Cancer Drugs Market, By Drug Class
2.2.2 North America Liver Cancer Drugs Market, By Country
2.2.2.1 U.S.
2.2.2.1.1 U.S. Liver Cancer Drugs Market, By Drug Class
2.2.2.2 Canada
2.2.2.2.1 Canada Liver Cancer Drugs Market, By Drug Class
2.3. Europe
2.3.1 Europe Liver Cancer Drugs Market, By Drug Class
2.3.2 Europe Liver Cancer Drugs Market, By Country
2.3.2.1 Germany
2.3.2.1.1 Germany Liver Cancer Drugs Market, By Drug Class
2.3.2.2 U.K.
2.3.2.2.1 U.K. Liver Cancer Drugs Market, By Drug Class
2.3.2.3 France
2.3.2.3.1 France Liver Cancer Drugs Market, By Drug Class
2.3.2.4 Italy
2.3.2.4.1 Italy Liver Cancer Drugs Market, By Drug Class
2.3.2.5 Spain
2.3.2.5.1 Spain Liver Cancer Drugs Market, By Drug Class
2.3.2.6 Rest of Europe
2.3.2.6.1 Rest of Europe Liver Cancer Drugs Market, By Drug Class
2.4. Asia-Pacific
2.4.1 Asia-Pacific Liver Cancer Drugs Market, By Drug Class
2.4.2 Asia-Pacific Liver Cancer Drugs Market, By Country
2.4.2.1 China
2.4.2.1.1 China Liver Cancer Drugs Market, By Drug Class
2.4.2.2 Japan
2.4.2.2.1 Japan Liver Cancer Drugs Market, By Drug Class
2.4.2.3 South Korea
2.4.2.3.1 South Korea Liver Cancer Drugs Market, By Drug Class
2.4.2.4 India
2.4.2.4.1 India Liver Cancer Drugs Market, By Drug Class
2.4.2.5 Singapore
2.4.2.5.1 Singapore Liver Cancer Drugs Market, By Drug Class
2.4.2.6 Rest of Asia
2.4.2.6.1 Rest of Asia Liver Cancer Drugs Market, By Drug Class
2.5. Rest of World
2.5.1 Rest of World Liver Cancer Drugs Market, By Drug Class
2.5.2 Rest of World Liver Cancer Drugs Market, By Country
2.5.2.1 Brazil
2.5.2.1.1 Brazil Liver Cancer Drugs Market, By Drug Class
2.5.2.2 Mexico
2.5.2.2.1 Mexico Liver Cancer Drugs Market, By Drug Class
2.5.2.3 South Africa
2.5.2.3.1 South Africa Liver Cancer Drugs Market, By Drug Class
2.5.2.4 Australia
2.5.2.4.1 Australia Liver Cancer Drugs Market, By Drug Class
2.5.2.5 ROW Countries
2.5.2.5.1 ROW Countries Liver Cancer Drugs Market, By Drug Class
ROW Countries Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 2. Targeted Therapy Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 7. Immunotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 12. Chemotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 17. Global Liver Cancer Drugs Market Value, By Region, 2022-2031, Million USD
TABLE 18. North America Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 19. North America Liver Cancer Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 20. U.S. Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 21. Canada Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 22. Europe Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 23. Europe Liver Cancer Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 24. Germany Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 25. U.K. Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 26. France Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 27. Italy Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 28. Spain Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 29. Rest of Europe Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 30. Asia-Pacific Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 31. Asia-Pacific Liver Cancer Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 32. China Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 33. Japan Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 34. South Korea Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 35. India Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 36. Singapore Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 37. Rest of Asia Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 38. Rest of World Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 39. Rest of World Liver Cancer Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 40. Brazil Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 41. Mexico Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 42. South Africa Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 43. Australia Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 44. ROW Countries Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD
ROW Countries Liver Cancer Drugs Market Value, By Drug Class, 2022-2031, Million USD

$2,000
$3,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings